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Abstract
Introduction Interleukin (IL)-23 is essential for the development
of various experimental autoimmune models. However, the role
of IL-23 in non-autoimmune experimental arthritis remains
unclear. Here, we examined the role of IL-23 in the non-
autoimmune antigen-induced arthritis (AIA) model. In addition,
the regulatory potential of IL-23 in IL-17A and retinoic acid-
related orphan receptor gamma t (RORγt) expression in CD4+
and TCRγδ+ T cells was evaluated systemically as well as at the
site of inflammation.
Methods Antigen-induced arthritis was induced in wild-type, IL-
23p19-deficient and IL-17 Receptor A - knockout mice. At
different time points, synovial cytokine and chemokine
expression was measured. At days 1 and 7 of AIA, splenocytes
and joint-infiltrating cells were isolated and analyzed for
intracellular IL-17A and interferon (IFN)-γ  ex-vivo  by flow
cytometry. In splenic CD4+ and TCRγδ+ T cells gene expression
was quantified by flow cytometry and quantitative PCR.
Results IL-23 was critical for full-blown AIA. Lack of IL-23 did
not prevent the onset of joint inflammation but stopped the
progression to a destructive synovitis. IL-23 regulated IL-17A
expression in CD4+ T cells in the spleen. Of note, IL-17A and
IFN-γ expression was reduced in CD4+ T cells in the inflamed
joints of IL-23p19-deficient mice. Interestingly, IL-23 was also
critical for the induction of IL-17A and RORγt but not IFN-γ in
TCRγδ+ T cells in the inflamed joints. The importance of the IL-
23/IL-17 axis was further confirmed using IL-17 Receptor A
knockout mice showing significantly milder AIA compared to
control mice, with a disease course comparable to that of IL-
23p19-deficient mice.
Conclusions These data show that IL-23 is critical for full-blown
expression of a non-autoimmune destructive arthritis and
regulates the proportion of IL-17A and IFN-γ-positive CD4+ T
cells at the site of inflammation. Furthermore, IL-23 regulates IL-
17A and RORγt expression in TCRγδ T cells in arthritis. These
findings indicate that regulating the IL-23 pathway may have
therapeutic potential in non-autoimmune arthritis.
Introduction
Interleukin (IL)-23 is a member of the IL-12 family and consists
of both an IL-23-specific p19 subunit, and of a p40 subunit
which is shared with IL-12 [1]. IL-23 is elevated in many
autoimmune diseases such as psoriasis, rheumatoid arthritis
(RA), multiple sclerosis (MS), and inflammatory bowel disease
(IBD) [2]. It has been shown in animal models that IL-23, and
not IL-12, is critical in the induction of autoimmunity [3-7].
Mice deficient for IL-23p19 were fully protected against colla-
gen-induced arthritis (CIA), experimental autoimmune enceph-
alomyelitis (EAE) and experimental autoimmune uveitis (EAU),
in contrast to IL-12p35 deficient mice [3,4,6]. Although initial
studies show that the development of autoimmunity was
through Th17 cells, recent data show that also Th1 cells are
able to induce pathology [6,8]. Thus, the role of Th17 and Th1
cells and their interaction in these models needs further clari-
AIA: antigen-induced arthritis; CFA: Complete Freund's Adjuvant; CIA: collagen-induced arthritis; mBSA: methylated Bovine Serum Albumin; MFI: 
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fication [9]. However, in all these autoimmune models it is evi-
dent that IL-23 is essential in their development. Still, it has not
been elucidated whether IL-23 is critical for the progression of
arthritis into a non-autoimmune destructive arthritis.
In collagen-immunized IL-23p19 knockout mice, no IL-17A-
producing CD4+ T cells were noted although no difference in
IFN-γ-producing CD4+ T cells was observed [4]. This indicates
that IL-17A plays an important role in the early phase of CIA
which is in line with earlier observations [10,11]. Apart from
Th17 cells, other cells such as CD8+, NKT, and TCRγδ+ T cells
are able to produce IL-17A [12,13] and it has been shown that
TCRγδ+ T cells produced relatively high levels of IL-17A in CIA
[14] and, in fact are the predominant source of IL-17-produc-
ing cells in the CIA joint [15]. Depletion of IL-17A-producing
Vγ4+ TCRγδ+ T cells resulted in a significant reduction of the
clinical disease score although mice were not fully protected
[14]. However, the role of IL-23 in regulating IL-17A produc-
tion in these TCRγδ+ T cells is unknown.
Here, our results revealed that IL-23 is essential for the devel-
opment of full-blown antigen-induced arthritis. We used IL-
23p19 knockout (IL-23p19KO) mice to demonstrate that lack
of IL-23 did not prevent the onset of joint inflammation but
stopped the progression to a destructive synovitis. In the joints
of IL-23p19KO mice, the proportions of IL-17A and IFN-γ-pos-
itive CD4+ T cells were reduced. TCRγδ+ T cells also required
IL-23 for IL-17A but not for IFN-γ production in the inflamed
joints. Of note, the transcription levels of RORγt were signifi-
cantly higher in TCRγδ+ T cells than in CD4+ T cells from wild
type mice. The importance of the IL-23/IL-17 axis was further
confirmed using IL-17 Receptor A knockout (IL-17RAKO)
mice showing a similar arthritis expression as IL-23p19KO
mice. Thus, IL-23 is critical for full-blown expression of a non-
autoimmune destructive arthritis. Furthermore, IL-23 regulates
IL-17A and RORγt expression in TCRγδ+ T cells during joint
inflammation.
Materials and methods
Antigen-induced arthritis
IL-23p19 knockout mice were kindly provided by Dr. N. Ghi-
lardi, Genentech Inc., San Francisco, CA, USA [16], and IL-17
Receptor A knockout mice by Dr. J. Tocker, Amgen Inc., Seat-
tle, WA, USA [17]. Both strains were backcrossed on the
C57BL/6 background for at least 10 generations. Mice were
kept under specific pathogen free conditions and provided
with food and water ad libitum. Mice between 8 and 12 weeks
of age were used for experiments. All experiments were
approved by the Dutch Animal Ethics Committee (DEC).
To induce AIA, methylated Bovine Serum Albumin (mBSA, 8
mg/mL) was emulsified in an equal volume of CFA containing
1 mg/mL heat-killed M. tuberculosis (H37Ra; Difco). At day 7,
mice were immunized intradermal with 100 μL mBSA/CFA.
One week later, 60 μg mBSA was injected intra-articular to
induce mono-arthritis. The severity of arthritis in the knee joint
was scored macroscopically on a scale of 0 to 2 after remov-
ing the skin. At different time points during AIA, rear limbs were
hematoxylin and eosin stained as previously described [18],
and the severity of joint infiltration and bone erosion was deter-
mined on a scale from 0 to 3 (0 = no infiltration, 1 = mild infil-
tration, 2 = moderate infiltration, 3 = maximal infiltration; 0 =
no erosion, 1 = mild erosion, 2 = moderate erosion and 3 =
maximal erosion).
Synovial cytokine levels
To measure synovial cytokine levels, patellae with adjacent
synovium was isolated from knee joints as described earlier
[18]. MCP-1, TNF-α, IL-6, IFN-γ, IL-12p70 and IL-10 were
measured using the cytometric bead array using the mouse
inflammation kit with a detection limit of 10 pg/ml (BD Bio-
sciences, Sunnyvale, CA, USA). I IL-17A was measured by
ELISA (R&D Systems, Minneapolis, MN, USA).
Single-cell isolation and flow-cytometric analyses
With Blendzyme3 (60 ug/ml, Roche Diagnostics, Mannheim,
Germany), cells from inflamed joints were isolated [18]. For
intracellular detection of cytokines, we stimulated splenocytes
or cells isolated from the joints with phorbol myristate acetate
(PMA) (0.05 μg/mL) and Ionomycin (0.5 μg/mL) in the pres-
ence of GolgiStop™ (BD Biosciences) for four hours. For intra-
cellular cytokine staining, cells were fixed using 2% PFA and
permeabilized in 0.5% saponin. For intracellular staining of
RORγt, T-bet and GATA-3, a Fixation and Permeabilization kit
(eBioscience, San Diego, CA, USA) was used. Samples were
acquired on a FACS Calibur or on a FACS CANTO flow
cytometer and analyzed using FlowJo (Tree Star, Inc., Ashland,
OR, USA) software.
Purification of effector t cells and in vitro t cell 
stimulation
CD3+CD4+ and CD3+TCRγδ+ T cells were FACS-sorted from
spleens obtained at day 7 of AIA using a FACS Aria cell sort-
ing system and BD FACS Diva software (BD Bioscience).
Purity of obtained fractions was >98%.
Quantitative PCR analyses
Total RNA of sorted CD3+CD4+ and CD3+TCRγδ+ T cells was
extracted, and DNaseI-treated RNA was used for cDNA syn-
thesis [18]. PCR primers were designed manually or using
ProbeFinder software (Roche Applied Science, Indianapolis,
IN, USA) and probes were chosen from the universal probe
library (Roche Applied Science). Quantitative realtime PCR
was performed using the ABI Prism 7900 HT sequence-
detection system (Applied Biosystems, Foster City, CA, USA)
and analyzed using SDS v2.3 software (Applied Biosystems).
The Ct values obtained were normalized to those of glycereral-
dehyde-3-phosphate dehydrogenase (GAPDH).Available online http://arthritis-research.com/content/11/6/R194
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Statistical analysis
Differences between groups were tested with the Mann-Whit-
ney U test or the unpaired student t-test. P values less than
0.05 were considered significant.
Results
IL-23 has a critical role in the progression of destructive 
arthritis
To investigate the role of IL-23 in the progression of a T cell
mediated destructive inflammatory arthritis, we induced anti-
gen-induced arthritis (AIA) in WT and IL-23p19 knockout (IL-
23p19KO) mice by immunization with methylated BSA
(mBSA) in Complete Freund's Adjuvant (CFA) and induced
mono-arthritis one week later by a single intra-articular injec-
tion of mBSA into the knee joint. Maximum arthritis score was
observed at day 4, which stayed high until day 10 (Figure 1A).
In contrast, in IL-23p19KO mice the onset of arthritis was not
prevented although significantly milder joint inflammation was
noted which decreased rapidly to almost normal at day 10.
Seven days after the induction of mono-arthritis, histological
Figure 1
IL-23 has a critical role in the progression of antigen-induced arthritis IL-23 has a critical role in the progression of antigen-induced arthritis. WT and IL-23p19KO mice were immunized with mBSA/CFA and one week 
later mono-arthritis was induced by injecting mBSA directly into the knee joints. A. Arthritis score was determined macroscopically at different time 
points. Mean values and SEM are given for 8 to 31 mice per group. Data are obtained from three separate experiments. * P < 0.001, WT vs IL-
23p19KO. B, Histological analyses of joint inflammation and, C, bone erosion after H&E staining. B and C, Mean values and SEM are given from two 
separate experiments with a total of 20 knee joints per group. D-F. Cytokine levels in synovial washouts taken at days 1, 2 and 7. G and H. IL-17A 
and IFN-γ levels in synovial washouts taken at day 1. Mean values and SEM are given for 5 to 10 washouts obtained from two separate experiments.Arthritis Research & Therapy    Vol 11 No 6    Cornelissen et al.
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analyses revealed significantly less joint infiltration (Figure 1B)
and bone erosion (Figure 1C) in IL-23p19KO mice than in WT
mice. These data show that IL-23 is required for the progres-
sion of AIA into destructive synovitis.
To gain insight in the local chemokine and cytokine expression,
synovial washouts from WT and IL-23p19KO mice were taken
at different time points during AIA. The highest expression of
MCP-1 was measured at day 1 which was significantly lower
in IL-23p19KO compared to WT mice (Figure 1D). TNF-α was
significantly lower in IL-23p19KO than in WT mice at days 1
and 2, and undetectable at day 7 (Figure 1E). Also IL-6 was
measured in synovial washouts but no statistical significant dif-
ferences of this cytokine were observed between WT and IL-
23p19KO mice at days 1 and 2 (Figure 1F). Of high interest,
IL-17A and IFN-γ levels were significantly lower in IL-
23p19KO than in WT mice at day 1 of AIA (Figure 1G and
1H). Of note, no IL-12p70 and IL-10 could be detected (data
not shown).
The induction of Th17 cells in antigen-induced arthritis is 
IL-23 dependent
To examine whether Th17 cells are induced in AIA, WT mice
were immunized with mBSA/CFA. Ten days after immuniza-
tion, the proportions of IL-17A+IFN-γ-, IL-17A+IFN-γ+ double
positive and IL-17A-IFN-γ+ CD4+ T cells were increased com-
pared to naïve mice (Figure 2A) indicating the induction of
both Th17 and Th1 cells in AIA.
Because the arthritis progression was IL-23 dependent, we
further examined the role of IL-23 on the formation of IL-17A
and IFN-γ-producing CD4+ T cells in this process. Spleno-
cytes were isolated from arthritic WT and IL-23p19KO mice at
days 1 and 7 of AIA. At both time points, the proportions of IL-
17A+IFN-γ- and IL-17A+IFN-γ+ double positive CD4+ T cells
were lower in IL-23p19KO than in WT mice, while the propor-
tion of IL-17A-IFN-γ+ CD4+ T cells was similar between both
groups (Figure 2B-D; Figure S1 in Additional file 1 shows the
FSC/SSC of total splenocytes from WT and IL-23p19KO
mice). In addition to the decrease of IL-17A-producing cells, a
significant reduction in IL-17F and IL-22 mRNA expression
was found in FACS-sorted splenic CD4+ T cells (Figure 2E-F).
IL-23 is essential for the induction of IL-17A and RORγt in 
TCRγδ+ T cells during arthritis
To investigate whether TCRγδ+ T cells were present during
AIA and able to produce IL-17A as was described for CIA
[14], we isolated splenocytes at days 1 and 7 of AIA. On day
1, a relatively high proportion of TCRγδ+IL-17A+ T cells was
detected in the spleen of WT mice, and this proportion was
elevated at day 7 (Figure 3A and 3C). Interestingly, on these
time points, a significantly lower proportion of TCRγδ+IL-17A+
T cells was present in IL-23p19KO than in WT mice (Figure
3A and 3C), which was not associated with lower numbers of
splenic TCRγδ+ T cells (Figure 3E). Of note, the proportion of
TCRγδ+IL-17A+ T cells was 15- to 27-fold reduced in IL-
23p19KO mice versus WT mice (Figure 3A and 3C) com-
pared to a two-fold reduction of CD4+IL-17A+ T cells (Figure
2B-D). The proportions of both IL-17A-positive TCRγδ+ and
CD4+ T cells isolated from the draining lymph-nodes were
substantially reduced in IL-23p19KO mice versus WT mice
(Figure S3 in Additional file 1). Notably, since the proportion of
IL-17A-positive CD4+ and TCRγδ+ T cells were not decreased
in splenocytes taken from naïve IL-23p19KO compared to
naïve WT mice, we can exclude that there is an intrinsic defi-
ciency of PMA/Ionomycin-induced IL-17A-production in IL-
23p19KO cells (Figure S2 in Additional file 1). These data
indicate that the IL-17A production in TCRγδ+ T cells during
AIA is highly IL-23 dependent.
Apart from IL-17A, we analyzed the production of IFN-γ by
TCRγδ+ T cells in WT and IL-23p19KO mice. From day 1 to
day 7, the proportion of TCRγδ+IFN-γ+ T cells was equally
increased in WT and IL-23p19KO mice (Figure 3B and 3D)
suggesting that IFN-γ production by TCRγδ+ T cells is inde-
pendent of IL-23.
Because it is not known whether the expression of IL-17F and
IL-22 in TCRγδ+ T cells is IL-23 mediated in vivo, we per-
formed quantitative PCR on FACS-sorted splenic TCRγδ+ T
cells from WT and IL-23p19KO mice isolated at day 7 of AIA.
Although we could not detect IL-22 mRNA; the expression of
IL-17F was markedly lower in IL-23p19KO TCRγδ+ T cells
compared to WT TCRγδ+ T cells (Figure 3F).
IL-23 regulates RORγt, but not T-bet, in TCRγδ+ T cells
Since the proportion of CD4+ IL-17A+IFN-γ- but not IL-17A-
IFN-γ+ T cells was significantly lower in IL-23p19KO than in
WT mice, we measured RORγt mRNA expression in FACS-
sorted splenic CD4+ and TCRγδ+ T cells isolated at day 7 of
AIA. In addition, RORγt, T-bet and GATA3 expression was
measured by intracellular protein-stainings. No GATA3
expression by flow cytometry was found in neither CD4+ nor in
TCRγδ+ T cells (data not shown). Figure 4A shows that RORγt
was decreased in CD4+ T cells from IL-23p19KO mice com-
pared to WT mice, while T-bet expression was similar (Figure
4B). In TCRγδ+ T cells, the expression of RORγt was also sig-
nificantly reduced by lack of IL-23p19 (Figure 4C), while T-bet
expression was similar between WT and IL-23p19KO γδ T
cells (Figure 4D). Interestingly, RORγt was expressed at
higher levels in WT TCRγδ+ T cells than in WT CD4+ T cells
(Figure 4E).
IL-23 is essential for local IL-17A-production by TCRγδ+ 
and CD4+ T cells
Since severe joint inflammation was observed in WT but not in
IL-23p19KO mice at day 7 of AIA (Figure 1A), we wondered
whether the proportions of IL-17A-producing cells in the
inflamed joints of WT and IL-23p19KO mice were different. A
significantly lower proportion of IL-17A, but not of IFN-γ-pro-Available online http://arthritis-research.com/content/11/6/R194
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Figure 2
The induction of Th17 cells in AIA is IL-23 mediated The induction of Th17 cells in AIA is IL-23 mediated. A. WT mice were immunized with mBSA/CFA and 10 days later splenocytes were isolated and 
stimulated for four hours with PMA/Ionomycin, gated for CD4+ T cells and analyzed for intracellular IL-17A and IFN-γ expression. Numbers indicate 
percentage of positive cells within each quadrant. B-D. Antigen-induced arthritis was induced in WT and IL-23p19KO mice and at days 1 and 7, 
after i.a. mBSA injection, the splenocytes were isolated and stimulated for 4 h with PMA/Ionomycin and analyzed for intracellular IL-17A and IFN-γ 
expression on a CD4+ T cell gate. B. Numbers indicate percentage of positive cells within each quadrant. C and D. Quantification of flow cytrometric 
analyses from B; mean values and SEM are given for 6 to 12 mice per group from two to four independent experiments. E and F. On day 7 of AIA, 
splenic CD3+CD4+ T cells were FACS-sorted and gene expression was analyzed by quantitative RT-PCR for IL-17F and IL-22 respectively. Mean 
values and SEM are given for three mice. P-values were calculated using the student t-test.
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ducing TCRγδ+ T cells was observed in the inflamed joints of
IL-23p19KO mice compared to WT mice (Figure 5A-C; Figure
S4 in Additional file 1 shows the gating-strategy we used to
plot TCRγδ+ T cells isolated from the joint). Interestingly, the
mean-fluorescent intensity (MFI) of WT IL-17A-producing
TCRγδ+ T cells was significantly higher than the MFI of these
cells in IL-23p19KO (Figure 5D). In contrast, the MFI of IFN-γ
in the IFN-γ-producing TCRγδ+ T cells was similar between IL-
23p19KO and WT controls (Figure 5E). In line with the
reduced level of inflammation observed in IL-23p19KO mice
(Figure 1B), the total number of TCRγδ+ T cells was lower in
the arthritic joints from IL-23p19KO mice than from WT mice
(Figure 5F).
At the site of inflammation, the proportions of CD4+  IL-
17A+IFN-γ-, IL-17A+IFN-γ+ double positive and IL-17A-IFN-γ+
T cells were markedly elevated compared to the spleen (Fig-
ures 2B-D and 5G-H). In addition, in IL-23p19KO mice, the
absolute numbers of CD4+ T cells were significantly lower
compared to WT mice (Figure 5I).
Critical role for the IL-23/IL-17 immune pathway in the 
progression of destructive arthritis
Since the proportions and numbers of IL-17A but also of IFN-
γ-producing CD4+ T cells in the inflamed joint were lower in IL-
23p19KO than in WT mice (Figure 5G-I), we investigated the
importance of IL-17A signaling using IL-17 receptor A knock-
out (IL-17RAKO) mice. IL-17RAKO mice showed a similar pat-
tern of arthritis as IL-23p19KO mice did, and this was
significantly suppressed in both mouse knockout strains com-
pared to WT mice (Figure 6A). The lack of IL-17R-signalling
did however not lead to a reduced proportion of IL-17A-posi-
tive CD4+ or TCRγδ+ T cells (Figure 6B).
Discussion
Our findings show for the first time that IL-23 is critical for full-
blown non-autoimmune antigen-induced arthritis. IL-23 defi-
ciency did not prevent the onset of joint inflammation but
stopped the progression to a destructive synovitis. In the
inflamed joint, IL-17A and IFN-γ-producing CD4+ T cells were
reduced under IL-23-deficient conditions. In addition, IL-23
Figure 3
IL-23 is critical for the induction of IL-17A and RORγt in TCRγδ T cells IL-23 is critical for the induction of IL-17A and RORγt in TCRγδ T cells. A and B. At days 1 and 7 of AIA, splenocytes were isolated and stimulated 
for four hours with PMA/Ionomycin, gated for CD3+TCRγδ+ T cells and analyzed for intracellular IL-17A and IFN-γ respectively. Numbers in quad-
rants indicate percentage of cytokine-positive cells. C and D. Quantification of flow cytrometric analyses from A and B for IL-17A and IFN-γ; mean 
values and SEM are given for three to six mice for day 1 and for nine mice for day 7. E. Cell counts of total amount of TCRγδ+ T cells present in 
spleen on day 1 and 7 of AIA in WT and IL-23p19KO mice. F. On day 7 of AIA, splenic CD3+TCRγδ+ T cells were FACS-sorted and IL-17F gene 
expression was analyzed by quantitative RT-PCR. Mean values and SEM are given for three mice. P-values were calculated using the student's t-
test.Available online http://arthritis-research.com/content/11/6/R194
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was also essential for the induction of IL-17A and RORγt, but
not for IFN-γ, in TCRγδ+ T cells both systemically and locally at
the site of inflammation. The importance of the IL-23/IL-17
immune pathway was confirmed by using IL-17RAKO mice
which developed arthritis similar to IL-23p19KO mice. These
data show that IL-23 is critical in the regulation of a non-
autoimmune inflammatory arthritis and that it regulates IL-17A
and RORγt expression in CD4+ and TCRγδ+ T cells.
IL-23 is required for Th17 function in vivo and is considered to
be a survival factor for these T cells [19,20]. TGF-β and IL-6 in
contrast to IL-23 are critical in Th17 polarization from naïve T
cells [21-23]. Interestingly, TGF-β and IL-6 drive the produc-
tion of IL-17A and IL-10 by T cells and restrain Th17 cell-medi-
ated pathology [24]. In addition, IL-23 promotes the
proinflammatory Th17 profile induced by TGF-β and IL-6 and
is required for IL-22 expression [[25,26] and Lubberts et al.
Figure 4
IL-23 is essential for RORγt expression in TCRγδ+ T cells IL-23 is essential for RORγt expression in TCRγδ + T cells. At day 7 of AIA, WT and IL-23p19KO mice were sacrificed and splenocytes were iso-
lated. A. CD3+CD4+ T cells were FACS-sorted and RORγt gene expression was analyzed by quantitative RT-PCR (left panel); RORγt was measured 
intracellular and CD4+ T cells were gated (right panel). B T-bet expression was measured intracellular and CD4+ T cells were gated. C. 
CD3+TCRγδ+ T cells were FACS-sorted and RORγt gene expression was analyzed by quantitative RT-PCR (left panel); RORγt was measured intra-
cellular and γδ+ T cells were gated (right panel). D. T-bet expression was measured intracellular and γδ+ T cells were gated. E. Comparison of the 
mRNA quantification of RORγt expression between FACS-sorted CD4+ and γδ+ T cells. Mean values and SEM are given for three mice and P-values 
were calculated using the student's t-test.Arthritis Research & Therapy    Vol 11 No 6    Cornelissen et al.
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unpublished observations]. In the present study, we found that
IL-23 deficiency did not prevent the onset of antigen-induced
arthritis. Although MCP-1, TNF-α, IL-17A and IFN-γ as well as
joint inflammation were suppressed in the early phase of arthri-
tis in IL-23p19KO compared to WT mice, these data indicate
that the early joint inflammatory responses in this non-autoim-
mune T cell mediated arthritis-model is at least partly IL-23
independent. In contrast, further progression of arthritis into a
chronic destructive arthritis is IL-23 dependent. In this stage of
the disease effector T cells migrate from the lymphoid tissues
to the inflamed joint and play an important role in the progres-
sion of arthritis. Whether this is solely a matter of Th17 cells or
that other IL-17A producing cells are involved as well needs
further investigation, especially since we now found that IL-23
regulates IL-17A production in TCRγδ+ T cells.
In addition to Th17 cells there are other IL-17A-producing T
cells such as CD8+, NKT and TCRγδ+ T cells [27-31]. A direct
Figure 5
IL-23 deficiency results in less IL-17 production in the inflamed joint IL-23 deficiency results in less IL-17 production in the inflamed joint. At day 7 of AIA, cells from the arthritic joints of WT and IL-23p19KO mice were 
isolated and stimulated for four hours with PMA/Ionomycin. A. Intracellular cytokine staining of TCRγδ+ T cells for IL-17. B. Intracellular cytokine 
staining of TCRγδ+ T cells for IFN-γ; data from A and B are representatives from three mice per group. C. Quantification of flow cytrometric analyses 
from A and B. D. MFI was calculated for TCRγδ+ IL-17+ T cells. E. MFI was calculated for TCRγδ+ IFN-γ+ T cells. F. Total numbers of TCRγδ+ T cells 
in the joints of arthritic WT and IL-23p19KO mice. C-F, Mean values and SEM are given for three mice and P-values were calculated using the stu-
dent t-test. G. Intracellular cytokine staining of CD4+ T cells for IL-17A and IFN-γ. Data are representatives of six mice per group. H. Quantification of 
flow cytrometric analyses from G. I. Total numbers of CD4+ T cells present in arthritic joints from WT and IL-23p19KO mice.Available online http://arthritis-research.com/content/11/6/R194
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Figure 6
IL-17 receptor signaling is critical for the progression of AIA IL-17 receptor signaling is critical for the progression of AIA. A. WT, IL-23p19KO and IL-17RAKO mice were immunized with mBSA/CFA and 
mono-arthritis was induced one week later by an i.a. injection of mBSA. At days 1, 2, 4, 7 and 10 macroscopic scores were assessed. Mean values 
and SEM are given for six mice per group. * P < 0.01 WT vs IL-23P19KO and #, P < 0.01 WT vs IL-17RAKO. B. At day 7 of AIA, splenocytes from 
WT, IL-23p19KO and IL-17RAKO were isolated and stimulated for four hours with PMA/Ionomycin and analyzed for intracellular IL-17A and IFN-γ 
expression on a CD4+ and TCRγδ+ T cell gate. Numbers indicate percentage of positive cells within each quadrant and each dot plot shows a repre-
sentative mouse from three mice per group analyzed.Arthritis Research & Therapy    Vol 11 No 6    Cornelissen et al.
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role for TCRγδ+  T cells in the pathogenesis of collagen-
induced arthritis has been demonstrated [32]. Interestingly,
these cells produced relatively high levels of IL-17A [14]. In
fact it has been shown that the number of IL-17-producing
Vγ4+ TCRγδ+ T cells in the draining lymph nodes was equal to
the number of CD4+ TCRαβ+ T h 1 7  c e l l s  [ 1 4 ]  a n d ,  m o s t
recently, it has been shown that the predominant IL-17-pro-
ducing T cells in the joint of CIA-mice are TCRγδ+ and not
CD4+ [15]. Depletion of Vγ4+ TCRγδ+ T cells significantly
reduced clinical disease scores and incidence of disease [14].
On the other hand, depletion of TCRγδ+ T cells did not prevent
or ameliorate but rather aggravate rat adjuvant arthritis [33].
Here, we found a relatively high percentage of IL-17-produc-
ing TCRγδ+ T cells in the spleen and inflamed joints of arthritic
wild type mice. Of note, in contrast to IL-17A and IL-17F, no
expression of IL-22 was detected in FACS-sorted splenic
TCRγδ+ T cells from WT arthritic mice. Of high interest, IL-23
regulates IL-17A production in TCRγδ+ T cells in spleen, lymph
nodes as well as in the inflamed joints. In contrast, no reduc-
tion in the proportion of IFN-γ-producing TCRγδ+ T cells was
noted in IL-23p19KO mice compared to WT mice. These data
show for the first time that the formation of IL-17A and RORγt-
expressing TCRγδ+ T cells is IL-23 dependent in vivo. How-
ever, this study does not reveal the contribution of IL-17A-pro-
ducing TCRγδ+ T cells in the arthritis process.
Th17 differentiation is driven by the orphan nuclear receptor
RORγt [34] and RORα [35]. We found that, compared to
CD4+  T cells, the expression of RORγt was substantially
higher in TCRγδ+ T cells, which corresponds with the higher
proportion of IL-17A-producing cells in the TCRγδ+ fraction
than in the CD4+ T cell pool. This suggests that in TCRγδ+ T
cells, as in Th17 cells, the production of IL-17A and perhaps
also of IL-17F is under control of RORγt, which is in line with
earlier observations in which it has been shown that in lung
and skin the largest population of RORγt+ T cells express the
γδ TCR and produce the highest levels of IL-17A [36]. In the
present study, a clear reduction of RORγt levels in IL-
23p19KO mice under arthritic conditions was observed. This
suggests that IL-23 regulates the induction of RORγt in γδ T
cells.
Next to regulation of CD4+ IL-17+IFN-γ- T cells by IL-23, data
from the present study also show marked reduction of CD4+
IL-17+IFN-γ+ double positive cells in the absence of IL-23 dur-
ing arthritis. The role and function of these double positive
cells in the inflammatory process is unknown. Since these
cells express both IL-17 and IFN-γ reflecting both Th17 and
Th1 cytokine activity, these cells might be even more patho-
genic than single IL-17+ or IFN-γ+ T cells. On the other hand,
these cells may represent the transition phase of Th17 into
Th1 cells. It has been shown that IFN-γ is protective against
bone erosion and the expression of IFN-γ in human arthritis is
accompanied with less joint destruction [37,38]. This might
indicate that the IL-17+IFN-γ+ double positive cells might be
less pathogenic compared to IL-17+IFN-γ- T cells in arthritis.
Although Th17 cells are more pathogenic in inducing autoim-
mune diseases than IFN-γ producing Th1 cells in mice [3,4,6],
it was shown that both Th1 and Th17 cells are able to induce
EAE after adaptive T cell transfer of these specific Th subsets
into nude mice although Th1 and Th17 cells induced different
pathology [8]. In this study we showed that the IL-23/IL-17A
immune pathway is critical for the progression of arthritis into
a chronic destructive synovitis in a non-autoimmune arthritis
model, which is in line with the critical pathogenic role for IL-
17A in the arthritis process [39]. Elevated levels of the pro-
inflammatory T cell cytokine IL-17A have been detected in syn-
ovia of RA patients[40,41]. IL-17A contributes to the patho-
genesis of destructive arthritis [42,43]. Important sources of
IL-17A in this disease are Th17 cells and potentially TCRγδ+ T
cells. This latter cell type was elevated in synovia from RA
patients with active synovitis and those RA patients with
increased synovial TCRγδ+ T cells had an increased tissue
inflammation score compared to RA synovia with few TCRγδ+
T cells [44]. However, this study does not show the domi-
nance of TCRγδ+ T cells compared with conventional TCRαβ
T cells. In collagen-induced arthritis, it has been shown that a
relatively high proportion of TCRγδ+ T cells are able to produce
IL-17A [14] and are present at relatively high cell numbers in
CIA joints [15].
In contrast, in the synovia of patients with established RA, only
few IL-17-producing TCRγδ T cells were present [15]. There-
fore, studies on early RA patient materials including synovial
tissue infiltrates are needed to evaluate the presence of IL-17-
producing TCRγδ T cells. Interestingly, CD4+CD45RO+IL-
17A+ T cells were found in treatment-naïve early RA patients
with active disease [45]. The present observation that IL-23
regulates IL-17A production in both Th17 cells and TCRγδ T
cells in experimental arthritis underscores the need for further
studies to unravel the potential of IL-23 as a therapeutic target
in the pathogenesis of human destructive arthritis.
In conclusion, this study shows that IL-23 is critical for full-
blown expression of a non-autoimmune destructive arthritis.
Furthermore, IL-23 regulates the formation of both CD4+ and
TCRγδ+ IL-17A-producing T cells. These data add new insight
to the role of IL-23 in the regulation of a non-autoimmune
inflammatory arthritis. Furthermore, these data show that IL-23
regulates IL-17A and RORγt expression in TCRγδ+ T cells dur-
ing joint inflammation. These findings may be relevant to other
chronic inflammatory conditions and infectious diseases as
well.
Conclusions
The aim of our study was to examine the role of IL-23 in the
non-autoimmune antigen-induced arthritis model. Additionally,
we investigated the regulatory potential of IL-23 in IL-17A and
RORγt expression in CD4+ and TCRγδ+ T cells from the spleen
and joints of arthritic mice. In the present study we showedAvailable online http://arthritis-research.com/content/11/6/R194
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that IL-23 is essential for the development of full-blown anti-
gen-induced arthritis; IL-23p19-deficiency did not prevent the
onset of joint inflammation but stopped the progression to a
destructive synovitis. Furthermore, in the inflamed joints of IL-
23p19KO mice, the proportion of IL-17A and IFN-γ-express-
ing CD4+  T cells were reduced whereas IL-23 was also
required for IL-17A but not for IFN-γ-producing TCRγδ+ T cells
in the inflamed joints. The transcription levels of RORγt were
significantly higher in TCRγδ+ T cells than in CD4+ T cells from
wild type arthritic mice. Finally, since CD4+IFN-γ+ cells were
lower in the inflamed joints of IL-23p19-deficient mice, we
confirmed the importance of the IL-23/IL-17 axis using IL-
17RA deficient mice showing a similar arthritis expression as
IL-23p19KO mice.
Thus, this study adds new insight to the role of IL-23 in the reg-
ulation of non-autoimmune arthritis. Furthermore, although it is
suggested that IL-23 is involved in IL-17A-production by
TCRγδ+ T cells, we show for the first time a direct in vivo role
for IL-23 in regulating IL-17A and RORγt expression by
TCRγδ+ cells. These findings indicate that regulating the IL-23
pathway may have therapeutic potential in non-autoimmune
arthritis.
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